Results 31 to 40 of about 2,661 (133)

Mir-421 in plasma as a potential diagnostic biomarker for precancerous gastric lesions and early gastric cancer [PDF]

PeerJ, 2019
Objective MicroRNA (miR)-421 plays a key role in cancer progression. It has been reported that circulating miR-421may be a potential tumor marker for the diagnosis of several cancers. However, the role of miR-421 in plasma as a potential biomarker in the
Jianlin Chen, Lihua Wu, Yifan Sun, Qi Yin, Xianhua Chen, Siqun Liang, Qingyan Meng, Haihua Long, Fangying Li, Changjun Luo, Xiaorong Xiao   +10 more
doaj   +2 more sources

Increases in tumor markers are associated with primary Sjögren’s syndrome-associated interstitial lung disease

Therapeutic Advances in Chronic Disease, 2020
Aims: Interstitial lung disease (ILD) is the most common type of pulmonary involvement of extraglandular complication in patients with primary Sjögren’s syndrome (pSS), but the diagnosis of pSS-associated ILD (pSS-ILD) is still challenging.
Lei Shi, Xiao-Lei Han, Hong-Xia Guo, Jia Wang, Yu-Ping Tang, Chong Gao, Xiao-Feng Li   +6 more
doaj   +1 more source

Risk factors and their diagnostic values for ocular metastases in invasive ductal carcinoma

Cancer Medicine, 2021
Invasive ductal carcinoma (IDC) is a major type of breast cancer. Ocular metastasis (OM) in IDC is rarely seen, but patients with OM often have a poor prognosis.
Rong‐Bin Liang, Kang Yu, Jie‐Li Wu, Jia‐Xiang Liu, Qi Lin, Biao Li, Yu‐Qing Zhang, Qian‐Min Ge, Qiu‐Yu Li, Hui‐Ye Shu, Yi Shao   +10 more
doaj   +1 more source

Diagnosis of malignant pleural effusion with combinations of multiple tumor markers: A comparison study of five machine learning models

The International Journal of Biological Markers, 2023
Background To evaluate the diagnostic value of combinations of tumor markers carcinoembryonic antigen (CEA), carbohydrate antigen (CA) 125, CA153, and CA19-9 in identifying malignant pleural effusion (MPE) from non-malignant pleural effusion (non-MPE ...
Yixi Zhang, Jingyuan Wang, Baosheng Liang, Hanyu Wu, Yangyu Chen   +4 more
doaj   +1 more source

Retracted: Serum Markers CA125, CA153, and CEA along with Inflammatory Cytokines in the Early Detection of Lung Cancer in High-Risk Populations

BioMed Research International
[This retracts the article DOI: 10.1155/2022/1394042.].
Biomed Research International
openaire   +2 more sources

Effects of coagulation function indicators and tumor markers on diagnosis and clinicopathological characteristics of endometrial cancer

The International Journal of Biological Markers, 2023
Background Endometrial cancer is currently the prevalent malignant cancer worldwide. Diagnostic efficiency of tumor markers is limited, and coagulation function indicators in endometrial cancer are less concerned. Methods This study attempted to evaluate
Huayan Li, Huifeng Liao, Bilin Jing, Yifeng Wang   +3 more
doaj   +1 more source

Cytokeratin19-2g2, a novel fragment of cytokeratin19 in serum, indicating a more invasive behavior and worse prognosis in breast cancer patients. [PDF]

PLoS ONE, 2013
BACKGROUND: Various studies have been searching for new tumor biomarkers for breast cancer for years. However, so far, few markers have been proved clinically useful except CA153.
Yanan Kong, Junye Wang, Wanli Liu, Qiaolun Chen, Juan Yang, Weidong Wei, Mingqing Wu, Lu Yang, Xinhua Xie, Ning Lv, Jiaoli Guo, Laisheng Li, Jie Gao, Xiaoming Xie, Shuqin Dai   +14 more
doaj   +1 more source

Application value of the treatment of breast cancer bone metastases with radioactive seed 125I implantation under CT-guidance

BMC Medical Imaging, 2022
Background To investigate the application value of the treatment of breast cancer bone metastases with radioactive seed 125I implantation under CT-guidance.
Haiwen Li, Maobo Wang, Zhenhua Zhu, Yingqiang Lu   +3 more
doaj   +1 more source

Identification of Flap Endonuclease 1 With Diagnostic and Prognostic Value in Breast Cancer

Frontiers in Oncology, 2021
ObjectiveThis study aims to identify the potential value of flap endonuclease 1 (FEN1) as a diagnostic and prognostic marker for breast cancer (BC).MethodsELISA was used to measure serum FEN1 levels and ECLIA for CA153 and CEA levels.
Min Wu, Min Wu, Pan Zhang, Penghui Wang, Zhen Fang, Yaqin Zhu, Yaqin Zhu   +6 more
doaj   +1 more source

Development of a prediction model with serum tumor markers to assess tumor metastasis in lung cancer

Cancer Medicine, 2020
Background This study aimed to explore the possibility of serum tumor markers (TMs) combinations in assessing tumor metastasis in patients with lung cancer.
Jiasi Wang, Yanpeng Chu, Jie Li, Fanwei Zeng, Min Wu, Tingjie Wang, Liangli Sun, Qianlai Chen, Pingxi Wang, Xiuqin Zhang, Fanxin Zeng   +10 more
doaj   +1 more source